<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1d3" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0167346</article-id>
<article-id pub-id-type="publisher-id">PONE-D-16-23835</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Mathematical and statistical techniques</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Meta-analysis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Mathematics</subject><subj-group><subject>Statistics (mathematics)</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Meta-analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Diagnostic medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Pain</subject><subj-group><subject>Abdominal pain</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Pain</subject><subj-group><subject>Abdominal pain</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Diagnostic medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Hemorrhage</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Hemorrhage</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Vascular medicine</subject><subj-group><subject>Hemorrhage</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Database and informatics methods</subject><subj-group><subject>Database searching</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Vascular medicine</subject><subj-group><subject>Angina</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Bioassays and physiological analysis</subject><subj-group><subject>Gastrointestinal analysis</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Nephrology</subject><subj-group><subject>Chronic kidney disease</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body fluids</subject><subj-group><subject>Blood</subject><subj-group><subject>Platelets</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body fluids</subject><subj-group><subject>Blood</subject><subj-group><subject>Platelets</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body fluids</subject><subj-group><subject>Blood</subject><subj-group><subject>Platelets</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body fluids</subject><subj-group><subject>Blood</subject><subj-group><subject>Platelets</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Hematology</subject><subj-group><subject>Blood</subject><subj-group><subject>Platelets</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular types</subject><subj-group><subject>Animal cells</subject><subj-group><subject>Blood cells</subject><subj-group><subject>Platelets</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Risk Factors Associated with Renal Involvement in Childhood Henoch-Schönlein Purpura: A Meta-Analysis</article-title>
<alt-title alt-title-type="running-head">Renal Involvement and Childhood Henoch-Schönlein Purpura</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Chan</surname>
<given-names>Han</given-names>
</name>
<xref ref-type="aff" rid="aff001"/>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Tang</surname>
<given-names>Yan-Ling</given-names>
</name>
<xref ref-type="aff" rid="aff001"/>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Lv</surname>
<given-names>Xiao-Hang</given-names>
</name>
<xref ref-type="aff" rid="aff001"/>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Zhang</surname>
<given-names>Gao-Fu</given-names>
</name>
<xref ref-type="aff" rid="aff001"/>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Wang</surname>
<given-names>Mo</given-names>
</name>
<xref ref-type="aff" rid="aff001"/>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Yang</surname>
<given-names>Hai-Ping</given-names>
</name>
<xref ref-type="corresp" rid="cor001">*</xref>
<xref ref-type="aff" rid="aff001"/>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Li</surname>
<given-names>Qiu</given-names>
</name>
<xref ref-type="corresp" rid="cor001">*</xref>
<xref ref-type="aff" rid="aff001"/>
</contrib>
</contrib-group>
<aff id="aff001"><addr-line>Department of Nephrology, Key Laboratory of the Ministry of Education, Children’s Hospital of Chongqing Medical University, Chongqing, People’s Republic of China</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Reboldi</surname>
<given-names>Gianpaolo</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>Universita degli Studi di Perugia, ITALY</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con">
<p><list list-type="simple"> <list-item><p><bold>Conceptualization:</bold> QL HC.</p></list-item> <list-item><p><bold>Data curation:</bold> HC.</p></list-item> <list-item><p><bold>Formal analysis:</bold> HC YLT XHL.</p></list-item> <list-item><p><bold>Funding acquisition:</bold> QL HPY.</p></list-item> <list-item><p><bold>Investigation:</bold> YLT XHL.</p></list-item> <list-item><p><bold>Methodology:</bold> QL HPY HC.</p></list-item> <list-item><p><bold>Project administration:</bold> QL HC.</p></list-item> <list-item><p><bold>Resources:</bold> QL HPY MW.</p></list-item> <list-item><p><bold>Software:</bold> HC GFZ.</p></list-item> <list-item><p><bold>Supervision:</bold> QL HPY.</p></list-item> <list-item><p><bold>Validation:</bold> HC YLT.</p></list-item> <list-item><p><bold>Visualization:</bold> YLT.</p></list-item> <list-item><p><bold>Writing – original draft:</bold> HC HPY.</p></list-item> <list-item><p><bold>Writing – review &amp; editing:</bold> HC HPY QL.</p></list-item></list>
</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">oyhp0708@163.com</email> (HPY); <email xlink:type="simple">liqiu809@126.com</email> (QL)</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>30</day>
<month>11</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>11</volume>
<issue>11</issue>
<elocation-id>e0167346</elocation-id>
<history>
<date date-type="received">
<day>14</day>
<month>6</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>11</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-year>2016</copyright-year>
<copyright-holder>Chan et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0167346"/>
<abstract>
<sec id="sec001">
<title>Background and objective</title>
<p>Henoch-Schönlein purpura (HSP) is an important cause of chronic kidney disease in children. This meta-analysis identified risk factors associated with renal involvement in childhood HSP.</p>
</sec>
<sec id="sec002">
<title>Methods</title>
<p>PubMed, Embase, and Web of Science were searched. The quality of all eligible studies was assessed using the Newcastle-Ottawa scale criteria. An analysis of possible risk factors was conducted to report the odds ratio (OR) and weighted mean difference (WMD).</p>
</sec>
<sec id="sec003">
<title>Results</title>
<p>Thirteen studies (2398 children) revealed 20 possible and 13 significant risk factors associated with renal involvement in HSP, with the following meta-analysis estimates of OR and WMD, with 95% confidence intervals: older age (0.90, 0.61–1.19); age &gt; 10 y (3.13, 1.39–7.07); male gender (1.36, 1.07–1.74); abdominal pain (1.94,1.24–3.04); gastrointestinal bleeding (1.86, 1.30–2.65); severe bowel angina (3.38, 1.17–9.80); persistent purpura (4.02, 1.22–13.25); relapse (4.70, 2.42–9.14); WBC &gt; 15 × 10<sup>9</sup>/L (2.42, 1.39–4.22); platelets &gt; 500 × 10<sup>9</sup>/L (2.98, 1.22–7.25); elevated antistreptolysin O (ASO) (2.17, 1.29–3.64); and decreased complement component 3 (C3) (3.13, 1.62–6.05). Factors not significantly associated with renal involvement were: blood pressure; orchitis; elevated C-reactive protein; elevated erythrocyte sedimentation rate (ESR); and elevated serum IgA/IgE or IgG. Arthritis/arthralgia may be a risk factor according to the criteria of the American College of Rheumatology (1.41, 1.01–1.96).</p>
</sec>
<sec id="sec004">
<title>Conclusion</title>
<p>The following are associated with renal involvement in pediatric HSP: male gender; &gt; 10 y old; severe gastrointestinal symptoms (abdominal pain, gastrointestinal bleeding, and severe bowel angina); arthritis/arthralgia; persistent purpura or relapse; WBC &gt; 15 × 10<sup>9</sup>/L; platelets &gt; 500 × 10<sup>9</sup>/L; elevated ASO; and low C3. Relevant clinical interventions for these risk factors may exert positive effects on the prevention of kidney disease during the early stages of HSP. However, the results should be interpreted cautiously due to the limitations of the studies.</p>
</sec>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001809</institution-id>
<institution>National Natural Science Foundation of China</institution>
</institution-wrap>
</funding-source>
<award-id>81270802, 81470946</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Li</surname>
<given-names>Qiu</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award002">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001809</institution-id>
<institution>National Natural Science Foundation of China</institution>
</institution-wrap>
</funding-source>
<award-id>81200520</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Yang</surname>
<given-names>Hai-Ping Ping</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>This work was supported by the National Natural Science Foundation of China (Grant numbers 81270802, 81470946, 81200520), <ext-link ext-link-type="uri" xlink:href="https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list" xlink:type="simple">https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list</ext-link>.</funding-statement>
</funding-group>
<counts>
<fig-count count="9"/>
<table-count count="3"/>
<page-count count="21"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec005" sec-type="intro">
<title>Introduction</title>
<p>Henoch-Schönlein purpura (HSP) is the most common small vessel vasculitis in childhood, with an annual incidence of 10–20 per 100,000. More than 90% of patients are younger than 10 years old [<xref ref-type="bibr" rid="pone.0167346.ref001">1</xref>]. The clinical features of HSP have been well described and are predominantly non-thrombocytopenic purpura, arthritis, abdominal pain, gastrointestinal bleeding, and glomerulonephritis. Numerous investigations suggest that HSP is not a self-limited disease as previously thought and may eventually develop into chronic kidney disease in childhood [<xref ref-type="bibr" rid="pone.0167346.ref002">2</xref>–<xref ref-type="bibr" rid="pone.0167346.ref003">3</xref>]. Long-term prognosis depends mainly on the severity of renal involvement, which may manifest as persistent hematuria, proteinuria, nephritic or nephrotic syndrome, or even renal failure [<xref ref-type="bibr" rid="pone.0167346.ref004">4</xref>]. To prevent or delay end-stage renal disease, identification of early-stage nephritis is crucial.</p>
<p>The risk factors associated with renal involvement in HSP are not well known although epidemiologic and clinical features and some abnormal laboratory findings have been suggested to have a predictive role [<xref ref-type="bibr" rid="pone.0167346.ref005">5</xref>]. In this meta-analysis, we assessed the quality of available evidence regarding risk factors that may predict renal involvement in childhood HSP, and present a summary of our results.</p>
</sec>
<sec id="sec006" sec-type="materials|methods">
<title>Methods</title>
<sec id="sec007">
<title>Literature search strategy</title>
<p>The databases PubMed, Embase, and Web of Science were searched for papers published from January 2000 to September 2016, using basic search terms from combined text and Medical Subject Heading (MeSH) terms, including a MeSH search using ‘Purpura, Henoch-Schönlein’ and a keyword search using the word ‘Henoch-Schönlein purpura’, and terms related to risk factors (including a MeSH search using ‘Risk Factors’, and a keyword search using the words ‘risk factors’). This search strategy was modified to fit each database. References from published review articles were reviewed to identify additional relevant studies (<xref ref-type="supplementary-material" rid="pone.0167346.s003">S1 Text</xref>). Cohort studies or case-control studies that evaluated the risk factors for developing HSP nephritis (HSPN) were included. Titles and abstracts of articles found were screened, and articles of interest were also selected for evaluation of the full article.</p>
</sec>
<sec id="sec008">
<title>Study selection criteria</title>
<p>Patients were diagnosed with HSP at &lt; 18 years of age, with consideration for the criteria of the American College of Rheumatology (ACR) [<xref ref-type="bibr" rid="pone.0167346.ref006">6</xref>] and definitions of the European League against Rheumatism (EULAR) [<xref ref-type="bibr" rid="pone.0167346.ref007">7</xref>], in which HSPN is defined as the presence of hematuria or proteinuria at two different times within 6 months of HSP onset. Renal involvement was defined as the presence of proteinuria, hematuria, or blood cell casts. The studies in our meta-analysis must include detailed information after the onset of HSP and the length of follow-up time should be increased at least up to 6 months. Thrombocytopenia and systemic lupus erythematosus at the onset were excluded.</p>
</sec>
<sec id="sec009">
<title>Data collection and data extraction</title>
<p>Studies were selected by 2 independent reviewers according to the predetermined inclusion criteria, and disagreements were resolved by a third reviewer. Case reports, genetic association studies, review articles, comments, meeting abstracts, and editorial comments were excluded. The extracted data included the studies’ characteristics (publication year), design features, participants (e.g., setting, ethnicity, case number, age, male/female ratio, positive cases of HSP and HSPN, factors (e.g., the laboratory predictors), and diagnostic criteria.</p>
</sec>
<sec id="sec010">
<title>Bias and quality assessments of the included studies</title>
<p>The recommended checklist of the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) initiative was used to assess the risk of bias of the included studies [<xref ref-type="bibr" rid="pone.0167346.ref008">8</xref>]. A quality assessment of the studies was performed using Newcastle-Ottawa scale, NOS (<ext-link ext-link-type="uri" xlink:href="http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp" xlink:type="simple">http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp</ext-link>), under three main categories: a selection of study; comparability of groups; and determination of outcomes [<xref ref-type="bibr" rid="pone.0167346.ref009">9</xref>].</p>
</sec>
<sec id="sec011">
<title>Statistical analysis</title>
<p>We estimated the odds ratio (OR) with 95% confidence interval (CI) for dichotomous outcomes. A random-effects model was used regardless of heterogeneity. Heterogeneity among trials was tested using the I<sup>2</sup> test and considered significant at I<sup>2</sup> &gt; 50% or <italic>P</italic>- value &lt; 0.1. The random effects model was used for the meta-analysis if there was significant heterogeneity. Subgroup analyses were conducted regarding interval levels in the risk factors (e.g., gender), quality of evidence, and diagnosed criteria. Sensitivity analyses were performed to evaluate the effect of each study on the pooled ORs. The presence of publication bias was also evaluated using the Begg’s and Egger’s test [<xref ref-type="bibr" rid="pone.0167346.ref010">10</xref>,<xref ref-type="bibr" rid="pone.0167346.ref011">11</xref>]. All statistical analyses were performed using Stata 12.0 software (Stata Corp, College Station, TX, (USA) [<xref ref-type="bibr" rid="pone.0167346.ref012">12</xref>].</p>
</sec>
</sec>
<sec id="sec012" sec-type="results">
<title>Results</title>
<sec id="sec013">
<title>Study selection and characteristics</title>
<p>Initially, 386 potentially relevant studies were considered (<xref ref-type="fig" rid="pone.0167346.g001">Fig 1</xref>), but only 13 studies satisfied the inclusion and exclusion criteria and were included in this meta-analysis (<xref ref-type="table" rid="pone.0167346.t001">Table 1</xref>). These studies were published between 2000 and 2016, and all of them are case-control studies. Two were conducted in Turkey, four in China, and one each in Japan, Korea, Spain, Brazil, Finland, Iran, and Thailand. Studies were performed in 2 major ethnic populations; 8 studies were conducted in Asia (6 East Asian), while 5 studies were conducted with Caucasians. Five studies used the criteria of the EULAR, and 8 used the criteria of the ACR. The 13 studies comprised 2398 children with HSP; 974 of these children had renal involvement.</p>
<fig id="pone.0167346.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0167346.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Flowchart of selection process for eligible studies (PRISMA 2009 flow diagram).</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0167346.g001" xlink:type="simple"/>
</fig>
<table-wrap id="pone.0167346.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0167346.t001</object-id>
<label>Table 1</label> <caption><title>Basic characteristics of included studies<xref ref-type="table-fn" rid="t001fn001"><sup>a</sup></xref></title></caption>
<alternatives>
<graphic id="pone.0167346.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0167346.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left" style="background-color:#DAEEF3"/>
<th align="left" style="background-color:#DAEEF3">Year</th>
<th align="left" style="background-color:#DAEEF3">Setting</th>
<th align="left" style="background-color:#DAEEF3">Ethnicity</th>
<th align="left" style="background-color:#DAEEF3">HSPN/HSP</th>
<th align="left" style="background-color:#DAEEF3">Age HSPN/HSP, y</th>
<th align="left" style="background-color:#DAEEF3">Risk factors <xref ref-type="table-fn" rid="t001fn002"><sup>b</sup></xref></th>
<th align="left" style="background-color:#DAEEF3">Criterion</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">Shin [<xref ref-type="bibr" rid="pone.0167346.ref015">15</xref>]</td>
<td align="left">2006</td>
<td align="left">Korea</td>
<td align="left">Asian</td>
<td align="left">78/128</td>
<td align="left">8.2 ± 3.1/6.7 ± 2.6</td>
<td align="left">1 2 3 4 5 6 7 8 9 10 11 12 14 17</td>
<td align="left">ACR</td>
</tr>
<tr>
<td align="left">Jauhola [<xref ref-type="bibr" rid="pone.0167346.ref013">13</xref>]</td>
<td align="left">2015</td>
<td align="left">Finland</td>
<td align="left">Caucasian</td>
<td align="left">102/121</td>
<td align="left">8.2 ± 3.8/6.2 ± 3.0</td>
<td align="left">1 2 4 7 8 13 14 15 16</td>
<td align="left">ACR</td>
</tr>
<tr>
<td align="left">Zhao [<xref ref-type="bibr" rid="pone.0167346.ref019">19</xref>]</td>
<td align="left">2015</td>
<td align="left">China</td>
<td align="left">Asian</td>
<td align="left">45/96</td>
<td align="left">7.8 ± 2.6</td>
<td align="left">1 2 3 4 7 10 11 12 13 17</td>
<td align="left">EULAR</td>
</tr>
<tr>
<td align="left">Elmas [<xref ref-type="bibr" rid="pone.0167346.ref016">16</xref>]</td>
<td align="left">2014</td>
<td align="left">Turkey</td>
<td align="left">Caucasian</td>
<td align="left">28/79</td>
<td align="left">8.7 ± 4.1/7.1 ± 3.0</td>
<td align="left">1 2 7 9 10 11 13 14 16</td>
<td align="left">EULAR</td>
</tr>
<tr>
<td align="left">Mao [<xref ref-type="bibr" rid="pone.0167346.ref020">20</xref>]</td>
<td align="left">2014</td>
<td align="left">China</td>
<td align="left">Asian</td>
<td align="left">267/268</td>
<td align="left">7.5 ± 2.7/6.4 ± 2.5</td>
<td align="left">1 2 7 9 10 11 14 16</td>
<td align="left">EULAR</td>
</tr>
<tr>
<td align="left">Anil [<xref ref-type="bibr" rid="pone.0167346.ref017">17</xref>]</td>
<td align="left">2011</td>
<td align="left">Turkey</td>
<td align="left">Caucasian</td>
<td align="left">192/238</td>
<td align="left">7.9 ± 2.8/7.5 ± 2.8</td>
<td align="left">1 2 6 8 9 11 13</td>
<td align="left">ACR</td>
</tr>
<tr>
<td align="left">Zhu [<xref ref-type="bibr" rid="pone.0167346.ref021">21</xref>]</td>
<td align="left">2014</td>
<td align="left">China</td>
<td align="left">Asian</td>
<td align="left">80/38</td>
<td align="left">10.41 ± 2.70</td>
<td align="left">1 2 7 8 9 14 15 17</td>
<td align="left">ACR</td>
</tr>
<tr>
<td align="left">Mariac [<xref ref-type="bibr" rid="pone.0167346.ref014">14</xref>]</td>
<td align="left">2001</td>
<td align="left">Spain</td>
<td align="left">Caucasian</td>
<td align="left">8/61</td>
<td align="left">6.9 ± 2.2/6.1 ± 3.3</td>
<td align="left">1 2 5 6 7 8 9 13 14</td>
<td align="left">ACR</td>
</tr>
<tr>
<td align="left">Kawasaki [<xref ref-type="bibr" rid="pone.0167346.ref018">18</xref>]</td>
<td align="left">2003</td>
<td align="left">Japan</td>
<td align="left">Asian</td>
<td align="left">15/69</td>
<td align="left">9.6 ± 3.7/8.7 ± 3.1</td>
<td align="left">1 4 7 14 16 17</td>
<td align="left">ACR</td>
</tr>
<tr>
<td align="left">Limpongsanurak [<xref ref-type="bibr" rid="pone.0167346.ref022">22</xref>]</td>
<td align="left">2011</td>
<td align="left">Thailand</td>
<td align="left">Asian</td>
<td align="left">11/156</td>
<td align="left">6.9 ± 2.6</td>
<td align="left">5 7 12</td>
<td align="left">ACR</td>
</tr>
<tr>
<td align="left">Luiz [<xref ref-type="bibr" rid="pone.0167346.ref023">23</xref>]</td>
<td align="left">2007</td>
<td align="left">Brazil</td>
<td align="left">Caucasian</td>
<td align="left">70/72</td>
<td align="left">——</td>
<td align="left">1 2 3 4 5 6 7 14</td>
<td align="left">ACR</td>
</tr>
<tr>
<td align="left">Wang [<xref ref-type="bibr" rid="pone.0167346.ref024">24</xref>]</td>
<td align="left">2016</td>
<td align="left">China</td>
<td align="left">Asian</td>
<td align="left">37/34</td>
<td align="left">8.6 ± 2.1</td>
<td align="left">1 2 7 11 14</td>
<td align="left">EULAR</td>
</tr>
<tr>
<td align="left">Nickavar [<xref ref-type="bibr" rid="pone.0167346.ref025">25</xref>]</td>
<td align="left">2012</td>
<td align="left">Iran</td>
<td align="left">Caucasian</td>
<td align="left">41/64</td>
<td align="left">7.3 ± 2.6/5.3 ± 2.7</td>
<td align="left">2 5 7</td>
<td align="left">EULAR</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p><sup>a</sup> All studies were case-control studies</p></fn>
<fn id="t001fn002"><p><sup>b</sup> Risk factor key: 1, age; 2, gender; 3, persistent purpura; 4, abdominal pain; 5, severe bowel angina; 6, gastrointestinal bleeding; 7, arthritis/arthralgia; 8, relapse; 9, leukocytosis; 10, thrombocytosis; 11, CRP; 12, ASO; 13, ESR; 14, IgA; 15, IgE; 16, IgG; 17, C3.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec014">
<title>Quality of evidence</title>
<p>NOS scale for case-control studies was applied to assess the quality of the evidence. Six studies were judged to be of high relative quality [<xref ref-type="bibr" rid="pone.0167346.ref013">13</xref>–<xref ref-type="bibr" rid="pone.0167346.ref018">18</xref>] and 7 were of medium quality [<xref ref-type="bibr" rid="pone.0167346.ref019">19</xref>–<xref ref-type="bibr" rid="pone.0167346.ref025">25</xref>]. In the selected studies, the controls were not community-based except for Jauhola [<xref ref-type="bibr" rid="pone.0167346.ref013">13</xref>] and Mariac [<xref ref-type="bibr" rid="pone.0167346.ref014">14</xref>]. An additional unclear confounder was not controlled within comparability categories, which may be a possible source of bias. In addition, all of the 7 medium-quality studies may contain bias due to a relatively short-term follow-up. (<xref ref-type="table" rid="pone.0167346.t002">Table 2</xref>)</p>
<table-wrap id="pone.0167346.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0167346.t002</object-id>
<label>Table 2</label> <caption><title>Newcastle-Ottawa quality assessment scale (case-control) for studies included in this meta-analysis</title></caption>
<alternatives>
<graphic id="pone.0167346.t002g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0167346.t002" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left" style="background-color:#DAEEF3"/>
<th align="left" style="background-color:#DAEEF3"/>
<th align="left" style="background-color:#DAEEF3">1</th>
<th align="left" style="background-color:#DAEEF3">2</th>
<th align="left" style="background-color:#DAEEF3">3</th>
<th align="left" style="background-color:#DAEEF3">4</th>
<th align="left" style="background-color:#DAEEF3">5</th>
<th align="left" style="background-color:#DAEEF3">6</th>
<th align="left" style="background-color:#DAEEF3">7</th>
<th align="left" style="background-color:#DAEEF3">8</th>
<th align="left" style="background-color:#DAEEF3">9</th>
<th align="left" style="background-color:#DAEEF3">10</th>
<th align="left" style="background-color:#DAEEF3">11</th>
<th align="left" style="background-color:#DAEEF3">12</th>
<th align="left" style="background-color:#DAEEF3">13</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">Was the case definition adequate</td>
<td align="left"><bold>a.</bold> Yes, with independent validation<xref ref-type="table-fn" rid="t002fn001">*</xref>; <bold>b.</bold> yes, e.g., record linkage or based on self-reports; <bold>c.</bold> no description</td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
</tr>
<tr>
<td align="left">Representativeness of the case</td>
<td align="left"><bold>a.</bold> Consecutive or obviously representative series of cases<xref ref-type="table-fn" rid="t002fn001">*</xref>; <bold>b.</bold> potential for selection biases or not stated</td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"><bold>●</bold></td>
<td align="left"/>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Selection of controls</td>
<td align="left"><bold>a.</bold> Community controls<xref ref-type="table-fn" rid="t002fn001">*</xref>; <bold>b.</bold> hospital controls; <bold>c.</bold> no description</td>
<td align="left"/>
<td align="left"><bold>●</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"><bold>●</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Definition of controls</td>
<td align="left"><bold>a.</bold> No history of disease (endpoint<xref ref-type="table-fn" rid="t002fn001">*</xref>; <bold>b.</bold> no description of source</td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
</tr>
<tr>
<td align="left">Comparability</td>
<td align="left"><bold>a.</bold> Study controls for_ _ _ _(selecting the most important factor)<xref ref-type="table-fn" rid="t002fn001">*</xref>; <bold>b.</bold> study controls for any additional factor<xref ref-type="table-fn" rid="t002fn001">*</xref></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
</tr>
<tr>
<td align="left">Ascertainment of exposure</td>
<td align="left"><bold>a.</bold> Secure record (e.g., surgical records)<xref ref-type="table-fn" rid="t002fn001">*</xref>; <bold>b.</bold> structured interview where blind to case/control status interview not blinded to case/control status<xref ref-type="table-fn" rid="t002fn001">*</xref>; <bold>d.</bold> written self-report or medical record only; <bold>e.</bold> no description</td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
</tr>
<tr>
<td align="left">Ascertainment for cases &amp; controls</td>
<td align="left"><bold>a.</bold> Yes<xref ref-type="table-fn" rid="t002fn001">*</xref> <bold>b.</bold> No</td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
</tr>
<tr>
<td align="left">Non-response rate</td>
<td align="left"><bold>a.</bold> Same rate for both groups<xref ref-type="table-fn" rid="t002fn001">*</xref>; <bold>b.</bold> non-respondents described; <bold>c.</bold> rate different and no designation</td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
<td align="left"><bold>●</bold></td>
</tr>
<tr>
<td align="left">Score</td>
<td align="left"/>
<td align="left">7</td>
<td align="left">8</td>
<td align="left">6</td>
<td align="left">7</td>
<td align="left">6</td>
<td align="left">7</td>
<td align="left">6</td>
<td align="left">8</td>
<td align="left">7</td>
<td align="left">6</td>
<td align="left">6</td>
<td align="left">6</td>
<td align="left">6</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001"><p>*Scored points</p></fn>
</table-wrap-foot>
</table-wrap>
<p>The control group of each study was selected from the same population as the case group and was confirmed without kidney damage after the follow-up period. Controls were selected independently by exposure status and without special clinical features. Both groups completed the follow-up time and had similar rates of non-response. To ensure an efficient and valid study, selection and restrict enrollment for patients was conducted in each study. In addition, a stratified analysis (e.g., gender, age, clinical manifestation) and logistic regression for multivariate analysis for confounding factors (except for Limpongsanurak [<xref ref-type="bibr" rid="pone.0167346.ref022">22</xref>] and Nickavar [<xref ref-type="bibr" rid="pone.0167346.ref025">25</xref>]) were conducted in all selected studies. All the analyzed risk factors were shown to be directly linked with renal damage.</p>
</sec>
<sec id="sec015">
<title>Results of meta-analysis</title>
<p>We observed a consistent significant association between 12 risk factors and renal involvement in childhood HSP: gender, age, abdominal pain, gastrointestinal bleeding, severe bowel angina, persistent or relapse purpura, WBC &gt; 15 × 10<sup>9</sup>/L, platelet count &gt; 500 × 10<sup>9</sup>/L, elevated ASO, and decreased complement component 3 (C3; <xref ref-type="table" rid="pone.0167346.t003">Table 3</xref> and Figs <xref ref-type="fig" rid="pone.0167346.g002">2</xref>–<xref ref-type="fig" rid="pone.0167346.g005">5</xref>). In addition, there was no association between girls with HSP and HSPN (OR 1.15; 95% CI [0.77–1.71]) where <italic>P</italic> = 0.12. Arthritis/arthralgia may be a risk factor according to the criteria of the ACR in our analysis (1.41, 1.01–1.96, <xref ref-type="fig" rid="pone.0167346.g006">Fig 6</xref>).</p>
<fig id="pone.0167346.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0167346.g002</object-id>
<label>Fig 2</label>
<caption>
<title/>
<p>Forest plots of OR/WMD estimates for the following risk factors: (A) age; (B) gender: (C) older age</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0167346.g002" xlink:type="simple"/>
</fig>
<fig id="pone.0167346.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0167346.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Forest plots of OR estimates for the following risk factors: abdominal pain; gastrointestinal bleeding; severe bowel angina; arthritis or arthralgia; blood pressure; orchitis; persistent purpura; relapse</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0167346.g003" xlink:type="simple"/>
</fig>
<fig id="pone.0167346.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0167346.g004</object-id>
<label>Fig 4</label>
<caption>
<title>Forest plots of OR estimates for the following risk factors: ASO; CRP; ESR; leukocytosis; thrombocytosis</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0167346.g004" xlink:type="simple"/>
</fig>
<fig id="pone.0167346.g005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0167346.g005</object-id>
<label>Fig 5</label>
<caption>
<title>Forest plots of OR estimates for the following risk factors: IgA; IgE; IgG; C3</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0167346.g005" xlink:type="simple"/>
</fig>
<fig id="pone.0167346.g006" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0167346.g006</object-id>
<label>Fig 6</label>
<caption>
<title>Result of sensitivity analysis and subgroup analysis on arthritis/ arthralgia.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0167346.g006" xlink:type="simple"/>
</fig>
<table-wrap id="pone.0167346.t003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0167346.t003</object-id>
<label>Table 3</label> <caption><title>Results of meta-analysis by system</title></caption>
<alternatives>
<graphic id="pone.0167346.t003g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0167346.t003" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left" style="background-color:#CCECFF"/>
<th align="left" style="background-color:#CCECFF">Possible risk factors</th>
<th align="left" style="background-color:#CCECFF">Inconclusive</th>
<th align="left" style="background-color:#CCECFF">Results</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left"/>
<td align="left">Age</td>
<td align="left"/>
<td align="left">Older age WMD = 0.90,95% CI (0.61–1.19), P = 0.00</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">&gt;10 year-old = 3.13,95% CI (1.39–7.07), <italic>P</italic> = 0.06</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Boy</td>
<td align="left"/>
<td align="left">OR = 1.36,95% CI (1.07–1.74), <italic>P</italic> = 0.02</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left">Girl</td>
<td align="left">OR = 1.15,95% CI (0.77–1.71), <italic>P</italic> = 0.15</td>
</tr>
<tr>
<td align="left">Digestive tract</td>
<td align="left">Abdominal pain</td>
<td align="left"/>
<td align="left">OR = 1.94,95% CI (1.24–3.04), <italic>P</italic> = 0.04</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Gastrointestinal bleeding</td>
<td align="left"/>
<td align="left">OR = 1.86,95% CI (1.30–2.65), <italic>P</italic> = 0.70</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Severe bowel angina</td>
<td align="left"/>
<td align="left">OR = 3.38,95% CI (1.17–9.80), <italic>P</italic> = 0.02</td>
</tr>
<tr>
<td align="left">Skeletal</td>
<td align="left">Arthritis/arthralgia</td>
<td align="left"/>
<td align="left">OR = 1.41,95% CI (1.01–1.96), <italic>P</italic> = 0.60</td>
</tr>
<tr>
<td align="left">Dermal</td>
<td align="left">Persistent purpura</td>
<td align="left"/>
<td align="left">OR = 4.02,95% CI (1.22–13.25), <italic>P</italic> = 0.02</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Relapse</td>
<td align="left"/>
<td align="left">OR = 4.70,95% CI (2.42–9.14), <italic>P</italic> = 0.00</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left">Blood pressure</td>
<td align="left">OR = 1.10,95% CI (0.63–1.92), <italic>P</italic> = 0.42</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left">Orchitis</td>
<td align="left">OR = 0.94,95% CI (0.30–2.94), <italic>P</italic> = 0.33</td>
</tr>
<tr>
<td align="left">Routine blood test</td>
<td align="left">WBC &gt; 15 × 10<sup>9</sup>/L</td>
<td align="left"/>
<td align="justify">OR = 2.42,95% CI (1.39–4.22), <italic>P</italic> = 0.00</td>
</tr>
<tr>
<td align="left"/>
<td align="left">PLT &gt; 500 × 10<sup>9</sup>/L</td>
<td align="left"/>
<td align="justify">OR = 2.98,95% CI (1.22–7.25), <italic>P</italic> = 0.02</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Positive ASO</td>
<td align="left"/>
<td align="left">OR = 2.17,95% CI (1.29–3.64), <italic>P</italic> = 0.00</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left">Elevated ESR</td>
<td align="left">OR = 0.90,95% CI (0.65–1.23), <italic>P</italic> = 0.33</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left">Elevated CRP</td>
<td align="left">OR = 1.33,95% CI (0.77–2.28), <italic>P</italic> = 0.06</td>
</tr>
<tr>
<td align="left">Immunologic function</td>
<td align="left"/>
<td align="left">Elevated IgA</td>
<td align="left">OR = 1.24,95% CI (0.65–2.37), <italic>P</italic> = 0.02</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left">Elevated IgE</td>
<td align="left">OR = 1.06,95% CI (0.45–2.49), <italic>P</italic> = 0.19</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left">Elevated IgG</td>
<td align="left">OR = 0.65,95% CI (0.22–1.90), <italic>P</italic> = 0.41</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Decreased C3</td>
<td align="left"/>
<td align="left">OR = 3.13,95% CI (1.62–6.05), <italic>P</italic> = 0.91</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
</sec>
<sec id="sec016">
<title>Subgroup and sensitivity analysis</title>
<p>Except for arthritis/arthralgia, the subgroup analysis showed no evidence of heterogeneity between ACR and EULAR (<xref ref-type="fig" rid="pone.0167346.g006">Fig 6</xref>). The sensitivity analysis showed that no individual study significantly altered the results, except for the medium-quality study of Zhao et al. [<xref ref-type="bibr" rid="pone.0167346.ref019">19</xref>], which was the main origin of heterogeneity in abdominal pain (<xref ref-type="fig" rid="pone.0167346.g007">Fig 7</xref>). After the deletion of the study, the heterogeneity vanished (<xref ref-type="fig" rid="pone.0167346.g008">Fig 8</xref>). A further analysis of studies of different quality revealed that although studies of higher quality may have a more positive effect than medium-quality studies, both had similar results (<xref ref-type="supplementary-material" rid="pone.0167346.s002">S2 Appendix</xref>). Therefore, the data of each study in the meta-analysis was relatively stable and credible.</p>
<fig id="pone.0167346.g007" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0167346.g007</object-id>
<label>Fig 7</label>
<caption>
<title>Result of sensitivity analysis on abdominal pain.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0167346.g007" xlink:type="simple"/>
</fig>
<fig id="pone.0167346.g008" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0167346.g008</object-id>
<label>Fig 8</label>
<caption>
<title>Forest plots of OR estimates for abdominal pain after the deletion of an unstable study.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0167346.g008" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec017">
<title>Publication bias</title>
<p>Assessment of publication bias using Egger’s and Begg’s tests showed that there was no potential publication bias among the included trials (e.g., gender; Egger’s test <italic>P</italic> = 0.46, Begg’s test, <italic>P</italic> = 0.78; <xref ref-type="fig" rid="pone.0167346.g009">Fig 9</xref>).</p>
<fig id="pone.0167346.g009" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0167346.g009</object-id>
<label>Fig 9</label>
<caption>
<title/>
<p>Assessment of Publication bias using (A) Egger’s and (B) Begg’s test.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0167346.g009" xlink:type="simple"/>
</fig>
</sec>
</sec>
<sec id="sec018" sec-type="conclusions">
<title>Discussion</title>
<p>The possible risk factors of renal involvement in childhood Henoch-Schönlein purpura have been reported during past 15 years. Future studies should include a better definition of patients at risk, and then treatment and clinical trials should be adapted to patients’ risk profiles [<xref ref-type="bibr" rid="pone.0167346.ref026">26</xref>]. The present study attempted to determine comprehensively the effect of a multitude of possible risk factors of renal involvement in childhood HSP. The risk factors included demographic features; (age, gender), clinical features; (gastrointestinal tract, skeletal system, skin, testicles, and blood pressure) and some abnormal laboratory findings (such as elevated ASO, elevated ESR, elevated CRP, elevated IgA/IgE/IgG and decreased C3).</p>
<p>A previous meta-analysis was published by Mao et al. [<xref ref-type="bibr" rid="pone.0167346.ref027">27</xref>], which suggested that older age; elevated blood pressure, C3, hemoglobin, and urea nitrogen; and decreased albumin were risk factors for renal damage in HSP patients. In detail, the analysis included 8 studies (12 possible risk factors) and comprised 1222 patients, most of which were experimental studies without follow-up and focused only on laboratory findings in HSP patients. To acquire adequate and reliable clinical literature, our meta-analysis adopted a strict search strategy and included 13 studies (additional 1176 patients and 20 possible risk factors) that concern not only abnormal laboratory findings, but also focus on other vital risk factors (e.g., epidemiological features and clinical manifestations) in children with HSP. Meanwhile, we further assessed heterogeneity by performing subgroup or sensitivity analyses of stratified risk factors (e.g., gender), quality of evidence, and diagnostic criteria of HSP which have a great bearing on the interpretation of the results. In addition, publication bias and potential confounding factors among the included trials were well analyzed in our meta-analysis.</p>
<p>The criteria of the ACR and EULAR were implemented to define HSP. Some studies have adopted the former, while others have utilized the European; Except for arthritis/ arthralgia sensitivity analyses have shown no evidence of heterogeneity observed between both. In fact, all patients with HSP complained of purpura without thrombocytopenia [<xref ref-type="bibr" rid="pone.0167346.ref028">28</xref>]. But while palpable purpura was found in 100% of the cases according to the ACR criteria, the EULAR criteria base a diagnosis of HSP on other symptoms [<xref ref-type="bibr" rid="pone.0167346.ref029">29</xref>].</p>
<p>The majority of patients were diagnosed between the ages of 2 and 10 years<sub>.</sub> Sano et al. [<xref ref-type="bibr" rid="pone.0167346.ref030">30</xref>] concluded that age older than 4 years was an independent risk factor for renal involvement, while according to Jauhola et al. [<xref ref-type="bibr" rid="pone.0167346.ref013">13</xref>] age over 8 years at onset was a risk factor for developing nephritis. Our present meta-analysis showed that older children were at higher risk of renal involvement than younger children. Furthermore, the subgroup analysis revealed that children over 10 years old were more likely to suffer HSPN. Therefore, careful attention should be paid especially to children older than 10 years at onset (<xref ref-type="table" rid="pone.0167346.t003">Table 3</xref> and <xref ref-type="fig" rid="pone.0167346.g002">Fig 2</xref>).</p>
<p>Our meta-analysis based on 10 studies showed that boys are at higher risk for renal involvement than girls. This result is similar to a previous epidemiological survey based on 1.1 million children younger than 17 years in West Midland which reported a boy-to-girl ratio of 1.2:1.0 [<xref ref-type="bibr" rid="pone.0167346.ref031">31</xref>].Male predominance has also been reported in other studies [<xref ref-type="bibr" rid="pone.0167346.ref016">16</xref>, <xref ref-type="bibr" rid="pone.0167346.ref032">32</xref>, <xref ref-type="bibr" rid="pone.0167346.ref033">33</xref>]. Male hormones may have a pathogenic role in the course of HSP [<xref ref-type="bibr" rid="pone.0167346.ref034">34</xref>], but other studies reported that HSPN was more common in girls [<xref ref-type="bibr" rid="pone.0167346.ref014">14</xref>, <xref ref-type="bibr" rid="pone.0167346.ref023">23</xref>] (<xref ref-type="table" rid="pone.0167346.t003">Table 3</xref> and <xref ref-type="fig" rid="pone.0167346.g002">Fig 2</xref>).</p>
<p>Digestive tract symptoms (abdominal pain, gastrointestinal bleeding, and severe bowel angina) and skeletal system symptoms (arthritis/arthralgia) are the predominant manifestations in HSP. The meta-analysis based on 4 studies showed that gastrointestinal bleeding also increased the risk of renal involvement. Even so, few published articles have recognized gastrointestinal bleeding as a risk factor in HSP, and more cohort studies are necessary to identify whether gastrointestinal bleeding is an independent risk factor of HSPN(<xref ref-type="table" rid="pone.0167346.t003">Table 3</xref> and <xref ref-type="fig" rid="pone.0167346.g003">Fig 3</xref>).</p>
<p>Our review showed that digestive tract symptoms (abdominal pain, gastrointestinal bleeding, and severe bowel angina) were strongly related to renal involvement. In a retrospective study of 141 patients with HSP, Zhao et al. [<xref ref-type="bibr" rid="pone.0167346.ref019">19</xref>] showed that abdominal pain was not related to HSPN. However, 45% of the patients were complicated with obesity and 29.8% of them had a long disease course. This was a distinctly different epidemiological feature from other studies, and the possibility of admission bias could explain the heterogeneity (<xref ref-type="fig" rid="pone.0167346.g007">Fig 7</xref>). Abdominal pain and severe bowel angina are both unpleasant when patients suffer gastrointestinal involvement in HSP. Our analysis suggested that the two levels of gastrointestinal reactions are essentially equivalent for predicting renal injury in HSP. The mechanism probably is due to early systemic corticosteroid administration for severe abdominal pain, which did not prevent severe renal involvement [<xref ref-type="bibr" rid="pone.0167346.ref035">35</xref>]. As gastrointestinal symptoms are easily missed in clinical practice, more attention should be paid to these patients (<xref ref-type="table" rid="pone.0167346.t003">Table 3</xref> and <xref ref-type="fig" rid="pone.0167346.g003">Fig 3</xref>).</p>
<p>The sensitivity analysis showed a completely different result regarding arthritis/arthralgia between the criteria of the ACR and EULAR and the difference between two criteria may help to explain. For skeletal system symptoms (arthritis/arthralgia), a relatively independent type of HSP according to the criteria of the EULAR, patients with arthritis/arthralgia onset were assigned equally to the HSP or HSPN group. This distribution to compare these groups would not be possible if the criteria of the ACR were adopted (<xref ref-type="table" rid="pone.0167346.t003">Table 3</xref> and <xref ref-type="fig" rid="pone.0167346.g003">Fig 3</xref>).</p>
<p>Most identified studies showed an important association between abnormal skin manifestations (persistent purpura or relapse) and HSPN [<xref ref-type="bibr" rid="pone.0167346.ref036">36</xref>]. According to our meta-analysis, the risk of renal damage in HSP children with persistent purpura is 1.22–13.25-fold that of patients without persistent purpura, and the incidence of purpura relapse with renal involvement is 2.7-11-fold that of those who had no relapse. The study of Rigante et al. [<xref ref-type="bibr" rid="pone.0167346.ref037">37</xref>] showed that only persistent purpura for more than one month was a risk of renal involvement in HSPN. The mechanism probably is due to persistent small vascular inflammation and immune complex deposition, which triggers a series of inflammatory reactions that may damage kidney tissues (<xref ref-type="table" rid="pone.0167346.t003">Table 3</xref> and <xref ref-type="fig" rid="pone.0167346.g003">Fig 3</xref>).</p>
<p>Our analysis showed that WBC &gt;15 × 10<sup>9</sup>/L and platelet count &gt;500 × 10<sup>9</sup>/L were highly correlated with renal involvement in HSP, and a WBC of 10 × 10<sup>9</sup>/L to 15 × 10<sup>9</sup>/L has no statistical link to renal involvement. The mechanism may be a tissue injury induced by inflammatory agents secreted by neutrophils triggered by an inflammation-induced factor [<xref ref-type="bibr" rid="pone.0167346.ref037">37</xref>]. Anti-neutrophil cytoplasmic antibody was found to predict renal damage induced by HSP [<xref ref-type="bibr" rid="pone.0167346.ref038">38</xref>]. Thrombocytosis may be an early and useful indicator, and early studies have suggested that reducing the platelet count may be an effective method to avoid renal involvement [<xref ref-type="bibr" rid="pone.0167346.ref039">39</xref>, <xref ref-type="bibr" rid="pone.0167346.ref040">40</xref>]. However, a systematic review and meta-analysis of 13 randomized controlled trials performed by Hahn et al. [<xref ref-type="bibr" rid="pone.0167346.ref041">41</xref>] revealed that there is no benefit in giving antiplatelet agents, such as dipyridamole and aspirin, to prevent kidney disease. Heparin may be effective but it is potentially dangerous and should be taken cautiously. Additionally, there are no evidence that prednisone is of benefit in preventing renal damage in HSP according to Hahn et al. [<xref ref-type="bibr" rid="pone.0167346.ref041">41</xref>] and Chartapisak et al. [<xref ref-type="bibr" rid="pone.0167346.ref042">42</xref>] (<xref ref-type="table" rid="pone.0167346.t003">Table 3</xref> and <xref ref-type="fig" rid="pone.0167346.g004">Fig 4</xref>).</p>
<p>ASO is an antibody specific to streptolysin, which indicates streptococcal infections. Most patients also had a history of upper respiratory tract infection [<xref ref-type="bibr" rid="pone.0167346.ref043">43</xref>] and a large proportion was infected with streptococci. Our analysis suggested that upper respiratory tract infection, especially streptococcal infection related to high ASO, precedes HSPN [<xref ref-type="bibr" rid="pone.0167346.ref044">44</xref>]. So far, the mechanism underlying an association between elevated upper respiratory tract infection with streptococcus and kidney damage in HSP is unknown. According to the analysis, elevated ESR and CRP are not related to HSPN (<xref ref-type="table" rid="pone.0167346.t003">Table 3</xref> and <xref ref-type="fig" rid="pone.0167346.g004">Fig 4</xref>).</p>
<p>From the reviewed literature, some patients with HSPN had low C3 (10%-20%), elevated IgA (20%-50%), or both [<xref ref-type="bibr" rid="pone.0167346.ref031">31</xref>]. Our analysis also revealed that low C3 is an independent risk factor in HSP, which is a feature of post-streptococcal glomerulonephritis. Fretzayas et al. [<xref ref-type="bibr" rid="pone.0167346.ref045">45</xref>] reported elevated IgA in 73% of all patients with HSP and in 95% of patients with HSPN, but latter studies did not confirm elevated IgA as a risk factor associated with HSPN. In our present analysis, elevated IgG and IgE may have no connection with HSPN. There were only two papers that reported a link between serum IgG and IgE and HSPN, but the data for our analysis was not sufficient to calculate the OR and obtain a reliable result (<xref ref-type="table" rid="pone.0167346.t003">Table 3</xref> and <xref ref-type="fig" rid="pone.0167346.g005">Fig 5</xref>).</p>
<p>Although some studies have claimed that high blood pressure and orchitis could be risk factors in HSP children, our meta-analysis showed that blood pressure and orchitis did not predict the occurrence of renal involvement (<xref ref-type="table" rid="pone.0167346.t003">Table 3</xref> and <xref ref-type="fig" rid="pone.0167346.g003">Fig 3</xref>).</p>
<p>In the meta-analysis, neither renal failure nor end stage renal disease were detected or described in the selected studies. HSP is more common among children than adults, but there are more end-stage renal disease events in adults [<xref ref-type="bibr" rid="pone.0167346.ref046">46</xref>]. However, management of HSP is difficult for pediatricians because of insufficient clinical data in adult stage. Previous studies reported that severity and persistence of proteinuria were predictive of eventual renal failure [<xref ref-type="bibr" rid="pone.0167346.ref047">47</xref>,<xref ref-type="bibr" rid="pone.0167346.ref048">48</xref>] while Butani [<xref ref-type="bibr" rid="pone.0167346.ref049">49</xref>] and Sanders and <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Wyatt%2520RJ%255BAuthor%255D&amp;cauthor=true&amp;cauthor_uid=18332712" xlink:type="simple">Wyatt</ext-link> [<xref ref-type="bibr" rid="pone.0167346.ref050">50</xref>]suggested that there are no clinical features or prognostic markers to reliably identify children at highest risk for disease progression. Limited numbers of patients and appropriate studies at presentation increase the difficulty in performing a meta-analysis of a link between HSPN and end stage renal disease. Therefore, a long-term follow-up should be conducted for children with HSPN to determine prognosis when there is renal involvement.</p>
<p>Early identification of the risk factors of renal involvement in HSP has important implications for intervention and management. A sensitive scoring system based on these risk factors at onset to predict HSPN may become a focus of research. For children with gastrointestinal tract symptoms at onset, early gastrointestinal endoscopy is a good tool for assisting diagnosis of HSP [<xref ref-type="bibr" rid="pone.0167346.ref051">51</xref>]. Children with more than one risk factor require more intervention than those who are without those risk factors. The effectiveness of relevant preventive actions has been confirmed: A clinical trial reported that leukocytapheresis could not only ameliorate gastrointestinal symptoms, but also prevent HSPN, persistent purpura, and relapse in HSP. For persistent purpura and relapse, cyproheptadine could help prevent or at least decrease the occurrence of HSPN in children [<xref ref-type="bibr" rid="pone.0167346.ref052">52</xref>].</p>
<p>Some shortcomings of the present meta-analysis should be considered. Firstly, our analysis was based only on case-control studies, and the above risk factors cannot be relied on as causal factors of renal involvement in HSP. The risk factors of renal injury in HSP remain unclear. Case reports that point to new risk factors are increasing every year, and these may be a source of confounding factors in the included studies. Secondly, measurements and missing data were not described in detail in most of the included studies, which may indicate a possible bias. Thirdly, grey literature was not considered, and only 2 major ethnic populations was included, which may result in reporting and ethnicity selection bias. Fourthly, although there is no statistical or clinical heterogeneity across the case-control studies, potential bias still exists because of the 2 HSP diagnostic systems. For atypical HSP children, we should take a cautious attitude towards the above risk factors. Finally, for several risk factors (e.g., age,leukocytosis, thrombocytosis, and elevated ASO), relevant literature is limited and verification from clinical data is required.</p>
</sec>
<sec id="sec019" sec-type="conclusions">
<title>Conclusions</title>
<p>In conclusion, our study highlights the following as factors associated with renal involvement in pediatric HSP: male gender, age &gt; 10 years, severe gastrointestinal symptoms (including abdominal pain, gastrointestinal bleeding, and severe bowel angina), arthritis/arthralgia, persistent purpura or relapse, WBC &gt; 15 × 10<sup>9</sup>/L, platelets &gt; 500 × 10<sup>9</sup>/L, elevated ASO, and decreased C3. More attention should be paid to those children who have one or more of the above risk factors, and a sensitive scoring system based on these risk factors at onset may help predict renal injury in HSP patients. Relevant clinical intervention may exert positive effects on the prevention of kidney disease in the early stage of HSP. Well-designed and conventionally reported studies with a considerable number of children with HSP are necessary to determine the possible link between these 13 risk factors and HSPN.</p>
</sec>
<sec id="sec020">
<title>Supporting Information</title>
<supplementary-material id="pone.0167346.s001" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pone.0167346.s001" xlink:type="simple">
<label>S1 Appendix</label>
<caption>
<title>PRISMA 2009 Checklist (DOC)</title>
<p>(DOC)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0167346.s002" mimetype="application/zip" position="float" xlink:href="info:doi/10.1371/journal.pone.0167346.s002" xlink:type="simple">
<label>S2 Appendix</label>
<caption>
<title/>
<p>Subgroup analysis for quality of evidence: (A) age; (B) male gender; (C) older age; (D) abdominal pain; (E) gastrointestinal bleeding; (F) severe bowel angina; (G) arthritis/arthralgia; (H) persistent purpura; (I) relapse; (J) leukocytosis; (K) thrombocytosis; (L) ASO; (M) C3</p>
<p>(ZIP)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0167346.s003" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pone.0167346.s003" xlink:type="simple">
<label>S1 Text</label>
<caption>
<title>Search strategy for each database</title>
<p>(DOC)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>We are grateful to Dr. Daoqi Wu and Dr. Shaojun Li for the technical assistance.</p>
</ack>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item><term>ACR</term>
<def><p>American College of Rheumatology</p></def>
</def-item>
<def-item><term>ASO</term>
<def><p>antistreptolysin O</p></def>
</def-item>
<def-item><term>C3</term>
<def><p>complement component 3</p></def>
</def-item>
<def-item><term>CRP</term>
<def><p>C-reactive protein</p></def>
</def-item>
<def-item><term>ESR</term>
<def><p>erythrocyte sedimentation rate</p></def>
</def-item>
<def-item><term>EULAR</term>
<def><p>European League Against Rheumatism</p></def>
</def-item>
<def-item><term>HSP</term>
<def><p>Henoch-Schönlein purpura</p></def>
</def-item>
<def-item><term>HSPN</term>
<def><p>Henoch-Schönlein purpura nephritis</p></def>
</def-item>
<def-item><term>OR</term>
<def><p>odds ratio</p></def>
</def-item>
<def-item><term>WBC</term>
<def><p>white blood cell</p></def>
</def-item>
<def-item><term>WMD</term>
<def><p>weighted mean difference</p></def>
</def-item>
</def-list>
</glossary>
<ref-list>
<title>References</title>
<ref id="pone.0167346.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gardner Medwin</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Dolezalova</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Cummins</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Southwood</surname> <given-names>TR</given-names></name>.<article-title>Incidence of Henoch-Schonlein purpura, Kawasaki disease,and rare vasculitides in children of different ethnic origins</article-title>.<source>Lancet</source>. <year>2002</year>; <volume>360</volume>(<issue>9341</issue>):<fpage>1197</fpage>–<lpage>1202</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0140-6736(02)11279-7" xlink:type="simple">10.1016/S0140-6736(02)11279-7</ext-link></comment> <object-id pub-id-type="pmid">12401245</object-id></mixed-citation></ref>
<ref id="pone.0167346.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Alfredo</surname> <given-names>CS</given-names></name>, <name name-style="western"><surname>Nunes</surname> <given-names>NA</given-names></name>, <name name-style="western"><surname>Len</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Barbosa</surname> <given-names>CM</given-names></name>, <name name-style="western"><surname>Terreri</surname> <given-names>MT</given-names></name>, <name name-style="western"><surname>Hilário</surname> <given-names>MO</given-names></name>. <article-title>Henoch-Schönlein purpura: recurrence and chronicity</article-title>. <source>J Pediatr</source>.<year>2007</year>;<volume>83</volume>(<issue>2</issue>):<fpage>177</fpage>–<lpage>800</lpage>.</mixed-citation></ref>
<ref id="pone.0167346.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Davin</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Coppo</surname> <given-names>R</given-names></name>.<article-title>Henoch-Schönlein purpura nephritis in children</article-title>.<source>Nature Reviews Nephrology</source>.<year>2014</year>;<volume>10</volume>:<fpage>563</fpage>–<lpage>573</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nrneph.2014.126" xlink:type="simple">10.1038/nrneph.2014.126</ext-link></comment> <object-id pub-id-type="pmid">25072122</object-id></mixed-citation></ref>
<ref id="pone.0167346.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ronkainen</surname> <given-names>J</given-names></name>,<name name-style="western"><surname>Nuutinen</surname> <given-names>M</given-names></name>,<name name-style="western"><surname>Koskimies</surname> <given-names>O</given-names></name>.<article-title>The adult kidney 24 years after childhood Henoch-Schönlein purpura: a retrospective cohort study</article-title>. <source>Lancet</source> <year>2002</year>; <volume>360</volume>: <fpage>666</fpage>–<lpage>700</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0140-6736(02)09835-5" xlink:type="simple">10.1016/S0140-6736(02)09835-5</ext-link></comment> <object-id pub-id-type="pmid">12241872</object-id></mixed-citation></ref>
<ref id="pone.0167346.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stewart</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Savage</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Bell</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>McCord</surname> <given-names>B</given-names></name>.<article-title>Long term renal prognosis of Henoch-Schonlein purpura in an unselected childhood population</article-title>.<source>Eur J Pediatr</source>.<year>1988</year>;<volume>147</volume>:<fpage>113</fpage>–<lpage>115</lpage>. <object-id pub-id-type="pmid">3366130</object-id></mixed-citation></ref>
<ref id="pone.0167346.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mills</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Michel</surname> <given-names>BA</given-names></name>, <name name-style="western"><surname>Bloch</surname> <given-names>DA</given-names></name>, <name name-style="western"><surname>Calabrese</surname> <given-names>LH</given-names></name>, <name name-style="western"><surname>Hunder</surname> <given-names>GG</given-names></name>,<name name-style="western"><surname>Arend</surname> <given-names>WP</given-names></name>, <etal>et al</etal>.<article-title>Criteria for the classification of Henoch-Schönlein purpura</article-title>.<source>Arthritis Rheum</source>.<year>1990</year>;<volume>33</volume>:<fpage>1114</fpage>–<lpage>1121</lpage>. <object-id pub-id-type="pmid">2202310</object-id></mixed-citation></ref>
<ref id="pone.0167346.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ozen</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Ruperto</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Dillon</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Bagga</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Barron</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Davin</surname> <given-names>JC</given-names></name>, <etal>et al</etal>. <article-title>EULAR/PRES endorsed consensus criteria for the classification of childhood vasculitis</article-title>. <source>Ann Rheum Dis</source>.<year>2006</year>; <volume>65</volume>:<fpage>936</fpage>–<lpage>941</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/ard.2005.046300" xlink:type="simple">10.1136/ard.2005.046300</ext-link></comment> <object-id pub-id-type="pmid">16322081</object-id></mixed-citation></ref>
<ref id="pone.0167346.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vandenbroucke</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>von Elm</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Altman</surname> <given-names>DG</given-names></name>, <name name-style="western"><surname>Gøtzsche</surname> <given-names>PC</given-names></name>, <name name-style="western"><surname>Mulrow</surname> <given-names>CD</given-names></name>, <name name-style="western"><surname>Pocock</surname> <given-names>SJ</given-names></name>, <etal>et al</etal>. <article-title>Strengthening the reporting of observational studies in epidemiology(STROBE):explanation andelaboration</article-title>. <source>PLoS Med</source>.<year>2007</year>;<volume>4</volume>: <fpage>1628</fpage>–<lpage>1654</lpage>.</mixed-citation></ref>
<ref id="pone.0167346.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stang</surname> <given-names>A</given-names></name>.<article-title>Critical evaluation of the Newcastle-Ottawa scale for the assessment of the assessment of the quality of nonrandomized studies in meta-ananlyses</article-title>.<source>Eur J Epidemiol</source>.<year>2010</year>;<volume>25</volume>(<issue>9</issue>):<fpage>603</fpage>–<lpage>605</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s10654-010-9491-z" xlink:type="simple">10.1007/s10654-010-9491-z</ext-link></comment> <object-id pub-id-type="pmid">20652370</object-id></mixed-citation></ref>
<ref id="pone.0167346.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Beggr</surname> <given-names>CB</given-names></name>, <name name-style="western"><surname>Mazumdar</surname> <given-names>M</given-names></name>. <article-title>Operating characteristics of a rank correlation test for publicationbias</article-title>.<source>Biometrics</source>.<year>1994</year>;<volume>50</volume>:<fpage>1088</fpage>–<lpage>1101</lpage>. <object-id pub-id-type="pmid">7786990</object-id></mixed-citation></ref>
<ref id="pone.0167346.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Egger</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Davey Smith</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Schneider</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Minder</surname> <given-names>C</given-names></name>.<article-title>Bias in meta-analysis detected by a simple graphical test</article-title>.<source>BMJ</source> <year>1997</year>;<volume>315</volume>:<fpage>629</fpage>–<lpage>634</lpage>. <object-id pub-id-type="pmid">9310563</object-id></mixed-citation></ref>
<ref id="pone.0167346.ref012"><label>12</label><mixed-citation publication-type="book" xlink:type="simple"><collab>Stata Corp</collab>.<year>2011</year>.<source>Stata Statistical Software: Release 12</source>.<publisher-loc>College Station, TX</publisher-loc>: <publisher-name>StataCorp LP</publisher-name>: Available from: <ext-link ext-link-type="uri" xlink:href="http://www.stata.com/support/faqs/resources/citing-software-documentation-faqs/" xlink:type="simple">http://www.stata.com/support/faqs/resources/citing-software-documentation-faqs/</ext-link>.</mixed-citation></ref>
<ref id="pone.0167346.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jauhola</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Ronkainen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Koskimies</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Ala-Houhala</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Arikoski</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Hölttä</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Renal manifestations of Henoch-Schönlein purpura in a 6-month prospective study of 223 children</article-title>.<source>Arch Dis Child</source>.<year>2010</year>;<volume>95</volume> (<issue>11</issue>):<fpage>877</fpage>–<lpage>882</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/adc.2009.182394" xlink:type="simple">10.1136/adc.2009.182394</ext-link></comment> <object-id pub-id-type="pmid">20852275</object-id></mixed-citation></ref>
<ref id="pone.0167346.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Calvino</surname> <given-names>MC</given-names></name>, <name name-style="western"><surname>Llorca</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Garcia Porrua</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Fernández-Iglesias</surname> <given-names>JL</given-names></name>, <name name-style="western"><surname>Rodriguez-Ledo</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>González-Gay</surname> <given-names>MA</given-names></name>. <article-title>Henoch-Schönlein purpura in children from Northwestern Spain:a 20-year epidemiological and clinical study</article-title>.<source>Medicine</source>.<year>2001</year>; <volume>80</volume>: <fpage>279</fpage>–<lpage>290</lpage>. <object-id pub-id-type="pmid">11552081</object-id></mixed-citation></ref>
<ref id="pone.0167346.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shin</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Park</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Shin</surname> <given-names>YH</given-names></name>, <name name-style="western"><surname>Hwang</surname> <given-names>DH</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>JH</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>JS</given-names></name>.<article-title>Predictive factors for nephritis, relapse and significant proteinuria in childhood Henoch-Schonlein purpura</article-title>.<source>Scand J Rheumatol</source>.<year>2006</year>;<volume>1</volume>(<issue>35</issue>):<fpage>56</fpage>–<lpage>60</lpage>.</mixed-citation></ref>
<ref id="pone.0167346.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Elmas</surname> <given-names>AT</given-names></name>, <name name-style="western"><surname>Tabel</surname> <given-names>Y</given-names></name>.<article-title>Platelet count in children with Henoch-Schonlein purpura relationship to renal involvement</article-title>. <source>Jour clinic labo Anal</source>.<year>2014</year>;<volume>0</volume>:<fpage>1</fpage>–<lpage>4</lpage>.</mixed-citation></ref>
<ref id="pone.0167346.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Anil</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Aksu</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Kara</surname> <given-names>OD</given-names></name>, <name name-style="western"><surname>Bal</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Anil</surname> <given-names>AB</given-names></name>, <name name-style="western"><surname>Yavascan</surname> <given-names>O</given-names></name>, <etal>et al</etal>.<article-title>Henoch-Schönlein purpura in children from western Turkey:a retrospective analysis of 430 cases</article-title>.<source>The Turkish Journal of Pediatrics</source>.<year>2009</year>;<volume>51</volume>:<fpage>429</fpage>–<lpage>436</lpage>. <object-id pub-id-type="pmid">20112597</object-id></mixed-citation></ref>
<ref id="pone.0167346.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kawasaki</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Suzuki</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Sakai</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Nemoto</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Nozawa</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Suzuki</surname> <given-names>S</given-names></name>, <etal>et al</etal>.<article-title>Clinical and pathological features of children with Henoch-Schonlein purpura nephritis:risk factors associated with poor prognosis</article-title>.<source>J Clinical Nephrology</source>.<year>2003</year>; <volume>60</volume>(<issue>3</issue>): <fpage>153</fpage>–<lpage>160</lpage>.</mixed-citation></ref>
<ref id="pone.0167346.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhao</surname> <given-names>YL</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>ZJ</given-names></name>, <name name-style="western"><surname>Bai</surname> <given-names>XM</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>YC</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>GH</given-names></name>, <name name-style="western"><surname>Yan</surname> <given-names>XY</given-names></name>.<article-title>Obesity increases the risk of renal involvement in children with Henoch-Schönlein purpura</article-title>. <source>J European journal of pediatrics</source>.<year>2015</year>;<fpage>1</fpage>–<lpage>7</lpage></mixed-citation></ref>
<ref id="pone.0167346.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mao</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Yin</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Zhou</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Zhou</surname> <given-names>W</given-names></name>.<article-title>Henoch-Schönlein purpura in 535 Chinese children:clinical features and risk factors for renal involvement</article-title>.<source>J Intern Medic Research</source>,<year>2014</year>;<volume>43</volume>(<issue>4</issue>):<fpage>1043</fpage>–<lpage>1049</lpage>.</mixed-citation></ref>
<ref id="pone.0167346.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhu</surname> <given-names>J-J</given-names></name>, <name name-style="western"><surname>Yi</surname> <given-names>Z-W</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>I-H</given-names></name>, <name name-style="western"><surname>Long</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>I</given-names></name>.<article-title>Clinical analysis of 118 cases of Henoch-Schonlein purpura nephritis in children</article-title>. <source>J Clin Dermatol</source>.<year>2014</year>; <volume>43</volume>(<issue>6</issue>):<fpage>336</fpage>–<lpage>339</lpage>.</mixed-citation></ref>
<ref id="pone.0167346.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Limpongsanurak</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Kietkajornkul</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Singalavanija</surname> <given-names>S</given-names></name>.<article-title>Predictive factor of severe renal involvement in children with Henoch-Schoenlein purpura</article-title>. <source>Medical Association of Thailand</source>.<year>2011</year>;<volume>94</volume>:<fpage>204</fpage>–<lpage>208</lpage>.</mixed-citation></ref>
<ref id="pone.0167346.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>De Almeida</surname> <given-names>JL</given-names></name>, <name name-style="western"><surname>Campos</surname> <given-names>LM</given-names></name>, <name name-style="western"><surname>Paim</surname> <given-names>LB</given-names></name>, <name name-style="western"><surname>Leone</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Koch</surname> <given-names>VH</given-names></name>,<name name-style="western"><surname>Silva</surname> <given-names>CA</given-names></name>. <article-title>Renal involvement in Henoch-Schönlein purpura: a multivariate analysis of initial prognostic factors</article-title>. <source>J Pediatr</source>.<year>2007</year>;<volume>83</volume>:<fpage>259</fpage>–<lpage>266</lpage>.</mixed-citation></ref>
<ref id="pone.0167346.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Zhu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Gao</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Wei</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Zhen</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Ma</surname> <given-names>Q</given-names></name>.<article-title>Henoch-Schönlein purpura with joint involvement: Analysis of 71 cases</article-title>.<source>Pediatric Rheumatology</source>.<year>2016</year>;<volume>14</volume>(<issue>1</issue>):<fpage>20</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/s12969-016-0080-x" xlink:type="simple">10.1186/s12969-016-0080-x</ext-link></comment> <object-id pub-id-type="pmid">27029321</object-id></mixed-citation></ref>
<ref id="pone.0167346.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nickavar</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Mehrazma</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Lahouti</surname> <given-names>A</given-names></name>. <article-title>Clinicopathologic Correlations in Henoch-Schonlein Nephritis</article-title>. <source>Iranian Journal of Kidney Diseases</source>. <year>2012</year> <month>Nov</month>; <volume>6</volume>(<issue>6</issue>):<fpage>437</fpage>–<lpage>440</lpage>. <object-id pub-id-type="pmid">23146981</object-id></mixed-citation></ref>
<ref id="pone.0167346.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Davin</surname> <given-names>JC</given-names></name>.<article-title>Henoch-Schönlein purpura nephritis: pathophysiology, treatment, and future strategy</article-title>. <source>Clin J Am Soc Nephrol</source>.<year>2011</year>;<volume>6</volume> (<issue>3</issue>): <fpage>679</fpage>–<lpage>689</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2215/CJN.06710810" xlink:type="simple">10.2215/CJN.06710810</ext-link></comment> <object-id pub-id-type="pmid">21393485</object-id></mixed-citation></ref>
<ref id="pone.0167346.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mao</surname> <given-names>Song</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>Jianhua</given-names></name>. <article-title>Risk factors for renal damage in Henoch-Schonlein purpura: a meta analysis</article-title>. <source>Int J Clin Exp Med</source> <year>2016</year>;<volume>9</volume>(<issue>2</issue>):<fpage>3607</fpage>–<lpage>3613</lpage>.Available at: <underline><ext-link ext-link-type="uri" xlink:href="http://ijcem.com/files/ijcem0016518.pdf" xlink:type="simple">http://ijcem.com/files/ijcem0016518.pdf</ext-link></underline></mixed-citation></ref>
<ref id="pone.0167346.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ghrahani</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Ledika</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Sapartini</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Setiabudiawan</surname> <given-names>B</given-names></name>.<article-title>Age of onset as a risk factor of renal involvement in Henoch-Schönlein purpura</article-title>.<source>J Asia Pac Allergy</source>.<year>2014</year>;<volume>4</volume>:<fpage>42</fpage>–<lpage>47</lpage>.</mixed-citation></ref>
<ref id="pone.0167346.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ozen</surname> <given-names>S</given-names></name>.<article-title>The spectrum of vasculitis in children</article-title>.<source>Clin Rheumatol</source>.<year>2002</year>;<volume>16</volume>:<fpage>411</fpage>–<lpage>425</lpage>.</mixed-citation></ref>
<ref id="pone.0167346.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sano</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Izumida</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Shimizu</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Ogawa</surname> <given-names>Y</given-names></name>.<article-title>Risk factors of renal involvement and significant proteinuria in Henoch-Schönlein purpura</article-title>.<source>Eur J Pediatr</source>.<year>2002</year>;<volume>161</volume>:<fpage>196</fpage>–<lpage>201</lpage>. <object-id pub-id-type="pmid">12014385</object-id></mixed-citation></ref>
<ref id="pone.0167346.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Trapani</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Micheli</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Grisolia</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Resti</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Chiappini</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Falcini</surname> <given-names>F</given-names></name>, <etal>et al</etal>.<article-title>Henoch Schönlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature</article-title>.<source>Semin Arthritis Rheum</source>.<year>2005</year>; <volume>35</volume>:<fpage>143</fpage>–<lpage>153</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.semarthrit.2005.08.007" xlink:type="simple">10.1016/j.semarthrit.2005.08.007</ext-link></comment> <object-id pub-id-type="pmid">16325655</object-id></mixed-citation></ref>
<ref id="pone.0167346.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cakır</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Orhan</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Mungan</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Sonmez</surname> <given-names>FM</given-names></name>, <name name-style="western"><surname>Aslan</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Kalyoncu</surname> <given-names>M</given-names></name>, <etal>et al</etal>.<article-title>Henoch-Schönlein purpura in northeastern Turkey</article-title>.<source>Ann Trop Paediatr</source>.<year>2006</year>;<volume>26</volume>:<fpage>59</fpage>–<lpage>65</lpage> <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1179/146532806X90628" xlink:type="simple">10.1179/146532806X90628</ext-link></comment> <object-id pub-id-type="pmid">16494706</object-id></mixed-citation></ref>
<ref id="pone.0167346.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Davin</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Weening</surname> <given-names>JJ</given-names></name>.<article-title>Henoch-Schönlein purpura: an update</article-title>. <source>Eur J Pediatr</source>.<year>2002</year>;<volume>160</volume>:<fpage>689</fpage>–<lpage>695</lpage>.</mixed-citation></ref>
<ref id="pone.0167346.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Garcia Porrua</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Calvino</surname> <given-names>MC</given-names></name>, <name name-style="western"><surname>Llorca</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Couselo</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Gonzalez Gay</surname> <given-names>MA</given-names></name>.<article-title>Henoch-Schönlein purpura in children and adults: clinical differences in a defined population</article-title>.<source>Semin Arthritis Rheum</source>.<year>2002</year>; <volume>32</volume>:<fpage>149</fpage>–<lpage>156</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1053/sarh.2002.33980" xlink:type="simple">10.1053/sarh.2002.33980</ext-link></comment> <object-id pub-id-type="pmid">12528079</object-id></mixed-citation></ref>
<ref id="pone.0167346.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jiang</surname> <given-names>JH</given-names></name>,<name name-style="western"><surname>Pu</surname> <given-names>XM</given-names></name>.<article-title>Plasma neutrophil vascular endothelial cell cytoplasm antibodies and antibody detection in Henoch-Schönlein</article-title>.<source>Skin and venereal disease</source>.<year>2008</year>;<volume>30</volume> (<issue>2</issue>): <fpage>3</fpage>–<lpage>4</lpage>.</mixed-citation></ref>
<ref id="pone.0167346.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chan</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>YB</given-names></name>.<article-title>Henoch-Schönlein purpura in children</article-title>.<source>Chinese journal of practical pediatrics</source>.<year>2001</year>;<volume>4</volume>:<fpage>193</fpage>–<lpage>196</lpage>.</mixed-citation></ref>
<ref id="pone.0167346.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rigante</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Candelli</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Federico</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Bartolozzi</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Porri</surname> <given-names>MG</given-names></name>, <name name-style="western"><surname>Stabile</surname> <given-names>A</given-names></name>.<article-title>Predictive factors of renal involvement or relapsing disease in children with Henoch-Schonlein purpura</article-title>.<source>Rheumatol Int</source>.<year>2005</year>;<volume>25</volume>(<issue>1</issue>):<fpage>45</fpage>–<lpage>48</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00296-004-0452-2" xlink:type="simple">10.1007/s00296-004-0452-2</ext-link></comment> <object-id pub-id-type="pmid">15007622</object-id></mixed-citation></ref>
<ref id="pone.0167346.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Farley</surname> <given-names>TA</given-names></name>, <name name-style="western"><surname>Gillespie</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Rasoulpour</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Tolentino</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Hadler</surname> <given-names>JL</given-names></name>, <name name-style="western"><surname>Hurwitz</surname> <given-names>E</given-names></name>.<article-title>Epidemiology of a cluster of Henoch-Schonlein purpura</article-title>. <source>Am J Dis Child</source>.<year>1989</year>;<volume>143</volume>:<fpage>798</fpage>–<lpage>803</lpage>. <object-id pub-id-type="pmid">2741850</object-id></mixed-citation></ref>
<ref id="pone.0167346.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>He</surname> <given-names>YY</given-names></name>, <name name-style="western"><surname>Song</surname> <given-names>HM</given-names></name>.<article-title>A randomized controlled study of heparin on treating Henoch-Schonlein purpura</article-title>.<source>Chinese Journal of Pediatrics</source>.<year>2002</year>;<volume>40</volume>:<fpage>99</fpage>–<lpage>102</lpage>.</mixed-citation></ref>
<ref id="pone.0167346.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Allen</surname> <given-names>DM</given-names></name>, <name name-style="western"><surname>Diamond</surname> <given-names>LK</given-names></name>, <name name-style="western"><surname>Howell</surname> <given-names>DA</given-names></name>.<article-title>Anaphylactoid purpura in children:review with a follow-up of the renal complications</article-title>. <source>AMA J Dis Childhood</source>.<year>1960</year>;<volume>99</volume>:<fpage>833</fpage>–<lpage>854</lpage>.</mixed-citation></ref>
<ref id="pone.0167346.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hahn</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Hodson</surname> <given-names>EM</given-names></name>, <name name-style="western"><surname>Willis</surname> <given-names>NS</given-names></name>, <name name-style="western"><surname>Craig</surname> <given-names>JC</given-names></name>. <article-title>Interventions for preventing and treating kidney disease in Henoch-Schönlein Purpura</article-title>. <source>Cochrane Database Syst Rev</source>.<year>2015</year> <month>Aug</month> <day>7</day>;(<issue>8</issue>):<fpage>CD005128</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/14651858.CD005128.pub3" xlink:type="simple">10.1002/14651858.CD005128.pub3</ext-link></comment> <object-id pub-id-type="pmid">26258874</object-id></mixed-citation></ref>
<ref id="pone.0167346.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chartapisak</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Opastirakul</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Hodson</surname> <given-names>EM</given-names></name>, <name name-style="western"><surname>Willis</surname> <given-names>NS</given-names></name>, <name name-style="western"><surname>Craig</surname> <given-names>JC</given-names></name>. <article-title>Interventions for preventing and treating kidney disease in Henoch-SchönleinPurpura</article-title>. <source>Cochrane Database Syst Rev</source>. <year>2009</year> <month>Jul</month> <day>8</day>;(<issue>3</issue>):<fpage>CD005128</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/14651858.CD005128.pub2" xlink:type="simple">10.1002/14651858.CD005128.pub2</ext-link></comment> <object-id pub-id-type="pmid">19588365</object-id></mixed-citation></ref>
<ref id="pone.0167346.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ai Sheyyab</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>El Shanti</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Ajlouni</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Batieha</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Daoud</surname> <given-names>AS</given-names></name>.<article-title>Henoch-Schönlein purpura:clinical experience and contemplations on a streptococcal association</article-title>.<source>J Trop Pediatr</source>.<year>1996</year>;<volume>42</volume>:<fpage>200</fpage>–<lpage>203</lpage>. <object-id pub-id-type="pmid">8816030</object-id></mixed-citation></ref>
<ref id="pone.0167346.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gonzalez Gay</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Calviño</surname> <given-names>MC</given-names></name>, <name name-style="western"><surname>Vazquez Lopez</surname> <given-names>ME</given-names></name>, <name name-style="western"><surname>Garcia Porrua</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Fernandez lglesias</surname> <given-names>JL</given-names></name>, <name name-style="western"><surname>Dierssen</surname> <given-names>T</given-names></name>, <etal>et al</etal>.<article-title>Implications of upper respiratory tract infections and drugs in the clinical spectrum of Henoch-Schönlein purpura in children</article-title>.<source>Clin Exp Rheumatol</source>.<year>2004</year>;<volume>22</volume>: <fpage>781</fpage>–<lpage>784</lpage>. <object-id pub-id-type="pmid">15638057</object-id></mixed-citation></ref>
<ref id="pone.0167346.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fretzayas</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Sionti</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Moustaki</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Papadimitriou</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Nicolaidou</surname> <given-names>P</given-names></name>.<article-title>Henoch-Schönlein purpura: a long-term prospective study in Greek children</article-title>.<source>J Clin Rheumatol</source>.<year>2008</year>;<volume>14</volume>(<issue>6</issue>):<fpage>324</fpage>–<lpage>331</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/RHU.0b013e31817a240a" xlink:type="simple">10.1097/RHU.0b013e31817a240a</ext-link></comment> <object-id pub-id-type="pmid">18703982</object-id></mixed-citation></ref>
<ref id="pone.0167346.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Audemard Verger</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Pillebout</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Guillevin</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Thervet</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Terrier</surname> <given-names>B</given-names></name>. <article-title>IgA vasculitis in adults: Diagnostic and therapeutic aspects</article-title>. <source>Autoimmun Rev</source>;<volume>14</volume>(<issue>7</issue>):<fpage>579</fpage>–<lpage>585</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.autrev.2015.02.003" xlink:type="simple">10.1016/j.autrev.2015.02.003</ext-link></comment> <object-id pub-id-type="pmid">25688001</object-id></mixed-citation></ref>
<ref id="pone.0167346.ref047"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Farine</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Poucell</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Geary</surname> <given-names>DL</given-names></name>, <name name-style="western"><surname>Baumal</surname> <given-names>R</given-names></name>. <article-title>Prognostic significance of urinary findings and renal biopsies in children with Henoch-Shönlein purpura nephritis</article-title>. <source>Clin Pediatr</source>. <year>1986</year> <month>May</month>; <volume>25</volume>(<issue>5</issue>):<fpage>257</fpage>–<lpage>259</lpage>.</mixed-citation></ref>
<ref id="pone.0167346.ref048"><label>48</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wakaki</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Ishikura</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Hataya</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Hamasaki</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Sakai</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Yata</surname> <given-names>N</given-names></name>, <etal>et al</etal>. <article-title>Henoch-Schönlein purpura nephritis with nephrotic state in children: predictors of poor outcomes</article-title>. <source>Pediatr Nephrol</source>. <year>2011</year>; <volume>26</volume>(<issue>6</issue>):<fpage>921</fpage>–<lpage>925</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00467-011-1827-8" xlink:type="simple">10.1007/s00467-011-1827-8</ext-link></comment> <object-id pub-id-type="pmid">21373776</object-id></mixed-citation></ref>
<ref id="pone.0167346.ref049"><label>49</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Butani</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Morgenstern</surname> <given-names>BZ</given-names></name>.<article-title>Long-term outcome in children after Henoch-Schonlein purpura nephritis</article-title>. <source>Clin Pediatr (Phila)</source>. <year>2007</year>;<volume>46</volume>(<issue>6</issue>):<fpage>505</fpage>–<lpage>511</lpage>.</mixed-citation></ref>
<ref id="pone.0167346.ref050"><label>50</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sanders</surname> <given-names>JT</given-names></name>, <name name-style="western"><surname>Wyatt</surname> <given-names>RJ</given-names></name>. <article-title>IgA nephropathy and Henoch-Schönlein purpura nephritis</article-title>. <source>Curr Opin Pediatr</source>. <year>2008</year> <month>Apr</month>; <volume>20</volume>(<issue>2</issue>):<fpage>163</fpage>–<lpage>170</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/MOP.0b013e3282f4308b" xlink:type="simple">10.1097/MOP.0b013e3282f4308b</ext-link></comment> <object-id pub-id-type="pmid">18332712</object-id></mixed-citation></ref>
<ref id="pone.0167346.ref051"><label>51</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nishyama</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Nakajima</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Ogihara</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Oota</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Kobayashi</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Yokoyama</surname> <given-names>K</given-names></name>, <etal>et al</etal>: <article-title>Endoscope images of Henoch-Schonlein purpura</article-title>. <source>Digestion</source>.<year>2008</year>;<volume>77</volume>(<issue>4</issue>):<fpage>236</fpage>.</mixed-citation></ref>
<ref id="pone.0167346.ref052"><label>52</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Oki</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Tsugawa</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Suzuki</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Ito</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Tanaka</surname> <given-names>H</given-names></name>.<article-title>Leukocytapheresis for the treatment of Henoch-Schonlein purpura refractory resistant to both prednisolone and intravenous immunoglobulin therapy</article-title>.<source>Rheumatol Int</source>. <year>2008</year>;<volume>28</volume>:<fpage>1181</fpage>–<lpage>1182</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00296-008-0610-z" xlink:type="simple">10.1007/s00296-008-0610-z</ext-link></comment> <object-id pub-id-type="pmid">18509652</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>